|
1
|
Ferlay J, Shin HR, Bray F, et al:
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int
J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Marioni G, Marchese-Ragona R, Cartei G, et
al: Current opinion in diagnosis and treatment of laryngeal
carcinoma. Cancer Treat Rev. 32:504–515. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Talamini R, Bosetti C, La Vecchia C, et
al: Combined effect of tobacco and alcohol on laryngeal cancer
risk: a case-control study. Cancer Causes Control. 13:957–964.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Menach P, Oburra HO and Patel A: Cigarette
smoking and alcohol ingestion as risk factors for laryngeal
squamous cell carcinoma at Kenyatta National Hospital, Kenya. Clin
Med Insights Ear Nose Throat. 5:17–24. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mohamadian Roshan N, Jafarian A,
Ayatollahi H, et al: Correlation of laryngeal squamous cell
carcinoma and infections with either HHV-8 or HPV-16/18. Pathol Res
Pract. 210:205–209. 2014.PubMed/NCBI
|
|
6
|
Hoffman HT, Porter K, Karnell LH, et al:
Laryngeal cancer in the United States: changes in demographics,
patterns of care, and survival. Laryngoscope. 116(Suppl 111): 1–13.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang B, Pan X, Cobb GP, et al: microRNAs
as oncogenes and tumor suppressors. Dev Biol. 302:1–12. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shah MY and Calin GA: MicroRNAs as
therapeutic targets in human cancers. Wiley Interdiscip Rev RNA.
5:537–548. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kong YW, Ferland-McCollough D, Jackson TJ,
et al: microRNAs in cancer management. Lancet Oncol. 13:e249–258.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Calin GA, Sevignani C, Dumitru CD, et al:
Human microRNA genes are frequently located at fragile sites and
genomic regions involved in cancers. Proc Natl Acad Sci USA.
101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yeung ML, Yasunaga J, Bennasser Y, et al:
Roles for microRNAs, miR-93 and miR-130b, and tumor protein
53-induced nuclear protein 1 tumor suppressor in cell growth
dysregulation by human T-cell lymphotrophic virus 1. Cancer Res.
68:8976–8985. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Du L, Schageman JJ, Subauste MC, et al:
miR-93, miR-98, and miR-197 regulate expression of tumor suppressor
gene FUS1. Mol Cancer Res. 7:1234–1243. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Singh B, Ronghe AM, Chatterjee A, et al:
MicroRNA-93 regulates NRF2 expression and is associated with breast
carcinogenesis. Carcinogenesis. 34:1165–1172. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fang L, Deng Z, Shatseva T, et al:
MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting
integrin-β8. Oncogene. 30:806–821. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fang L, Du WW, Yang W, et al: MiR-93
enhances angiogenesis and metastasis by targeting LATS2. Cell
Cycle. 11:4352–4365. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fu X, Tian J, Zhang L, et al: Involvement
of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in
regulation of chemotherapeutic drug cisplatin chemosensitivity in
ovarian cancer cells. FEBS Lett. 586:1279–1286. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu S, Patel SH, Ginestier C, et al:
MicroRNA93 regulates proliferation and differentiation of normal
and malignant breast stem cells. PLoS Genet. 8:e10027512012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bennin DA, Don AS, Brake T, et al: Cyclin
G2 associates with protein phosphatase 2A catalytic and regulatory
B’ subunits in active complexes and induces nuclear aberrations and
a G1/S phase cell cycle arrest. J Biol Chem. 277:27449–27467. 2002.
View Article : Google Scholar
|
|
19
|
Burgering BM and Kops GJ: Cell cycle and
death control: long live Forkheads. Trends Biochem Sci. 27:352–360.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Martínez-Gac L, Marqués M, García Z, et
al: Control of cyclin G2 mRNA expression by forkhead transcription
factors: novel mechanism for cell cycle control by phosphoinositide
3-kinase and forkhead. Mol Cell Biol. 24:2181–2189. 2004.PubMed/NCBI
|
|
21
|
Arachchige Don AS, Dallapiazza RF, Bennin
DA, et al: Cyclin G2 is a centrosome-associated nucleocytoplasmic
shuttling protein that influences microtubule stability and induces
a p53-dependent cell cycle arrest. Exp Cell Res. 312:4181–4204.
2006.
|
|
22
|
Cao P, Zhou L, Zhang J, et al:
Comprehensive expression profiling of microRNAs in laryngeal
squamous cell carcinoma. Head Neck. 35:720–728. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang L, Wang Q, Li HL, et al: Expression
of MiR200a, miR93, metastasis-related gene RECK and MMP2/MMP9 in
human cervical carcinoma--relationship with prognosis. Asian Pac J
Cancer Prev. 14:2113–2118. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim BH, Hong SW, Kim A, et al: Prognostic
implications for high expression of oncogenic microRNAs in advanced
gastric carcinoma. J Surg Oncol. 107:505–510. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu D, He XX, Chang Y, et al:
Downregulation of MiR-93 expression reduces cell proliferation and
clonogenicity of HepG2 cells. Hepatogastroenterology. 59:2367–2373.
2012.PubMed/NCBI
|
|
26
|
Chen L, Jiang M, Yuan W, et al: Prognostic
value of miR-93 overexpression in resectable gastric
adenocarcinomas. Acta Gastroenterol Belg. 75:22–27. 2012.PubMed/NCBI
|
|
27
|
Montanini L, Lasagna L, Barili V, et al:
MicroRNA cloning and sequencing in osteosarcoma cell lines:
differential role of miR-93. Cell Oncol (Dordr). 35:29–41. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yu XF, Zou J, Bao ZJ, et al: miR-93
suppresses proliferation and colony formation of human colon cancer
stem cells. World J Gastroenterol. 17:4711–4717. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun GG, Zhang J and Hu WN: CCNG2
expression is down-regulated in colorectal carcinoma and its
clinical significance. Tumour Biol. 35:3339–3346. 2014. View Article : Google Scholar
|
|
30
|
Cui DW, Sun GG and Cheng YJ: Change in
expression of cyclin G2 in kidney cancer cell and its significance.
Tumour Biol. 35:3177–3183. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen JQ, Liu CJ, Wen HX, et al: Changes in
the expression of cyclin G2 in esophageal cancer cell and its
significance. Tumour Biol. 35:3355–3362. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim Y, Shintani S, Kohno Y, et al: Cyclin
G2 dysregulation in human oral cancer. Cancer Res. 64:8980–8986.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sun GG, Hu WN, Cui DW, et al: Decreased
expression of CCNG2 is significantly linked to the malignant
transformation of gastric carcinoma. Tumour Biol. 35:2631–2639.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cui DW, Cheng YJ, Jing SW, et al: Effect
of cyclin G2 on proliferative ability of prostate cancer PC-3 cell.
Tumour Biol. 35:3017–3024. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ito Y, Yoshida H, Uruno T, et al:
Decreased expression of cyclin G2 is significantly linked to the
malignant transformation of papillary carcinoma of the thyroid.
Anticancer Res. 23:2335–2338. 2003.PubMed/NCBI
|
|
36
|
Jiao J, Qin Z, Li S, et al: Potential role
of Notch1 signaling pathway in laryngeal squamous cell carcinoma
cell line Hep-2 involving proliferation inhibition, cell cycle
arrest, cell apoptosis, and cell migration. Oncol Rep. 22:815–823.
2009.PubMed/NCBI
|
|
37
|
Ren J, Zhu D, Liu M, et al: Downregulation
of miR-21 modulates Ras expression to promote apoptosis and
suppress invasion of Laryngeal squamous cell carcinoma. Eur J
Cancer. 46:3409–3416. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Che XH, Chen H, Xu ZM, et al:
14-3-3epsilon contributes to tumour suppression in laryngeal
carcinoma by affecting apoptosis and invasion. BMC Cancer.
10:3062010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tian L, Li M, Ge J, et al: MiR-203 is
downregulated in laryngeal squamous cell carcinoma and can suppress
proliferation and induce apoptosis of tumours. Tumour Biol.
35:5953–5963. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Horne MC, Goolsby GL, Donaldson KL, et al:
Cyclin G1 and cyclin G2 comprise a new family of cyclins with
contrasting tissue-specific and cell cycle-regulated expression. J
Biol Chem. 271:6050–6061. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Horne MC, Donaldson KL, Goolsby GL, et al:
Cyclin G2 is up-regulated during growth inhibition and B cell
antigen receptor-mediated cell cycle arrest. J Biol Chem.
272:12650–12661. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bates S, Rowan S and Vousden KH:
Characterisation of human cyclin G1 and G2: DNA damage inducible
genes. Oncogene. 13:1103–1109. 1996.PubMed/NCBI
|
|
43
|
Wang DH, Hu JR, Wang LY, et al: The
apoptotic function analysis of p53, Apaf1, Caspase3 and Caspase7
during the spermatogenesis of the Chinese fire-bellied newt
Cynops orientalis. PLoS One. 7:e399202012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Johansson N, Ahonen M and Kähäri VM:
Matrix metalloproteinases in tumor invasion. Cell Mol Life Sci.
57:5–15. 2000. View Article : Google Scholar
|
|
45
|
Fink K and Boratyński J: The role of
metalloproteinases in modification of extracellular matrix in
invasive tumor growth, metastasis and angiogenesis. Postepy Hig Med
Dosw (Online). 66:609–628. 2012.(In Polish).
|
